- Home
- Publications
- Publication Search
- Publication Details
Title
Liquid Biopsy, ctDNA Diagnosis through NGS
Authors
Keywords
-
Journal
Life-Basel
Volume 11, Issue 9, Pages 890
Publisher
MDPI AG
Online
2021-08-31
DOI
10.3390/life11090890
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liquid biopsy enters the clinic — implementation issues and future challenges
- (2021) Michail Ignatiadis et al. Nature Reviews Clinical Oncology
- Decoding the Evolutionary Response to Ensartinib in ALK-Positive Non-Small-Cell Lung Cancer Patients by Dynamic Circulating Tumor DNA Sequencing
- (2021) Yunpeng Yang et al. Journal of Thoracic Oncology
- Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
- (2021) Filippo Martignano et al. Molecular Cancer
- Serial circulating tumor DNA identification associated with the efficacy and prognosis of neoadjuvant chemotherapy in breast cancer
- (2021) Yidong Zhou et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment
- (2021) Naoko Sueoka‐Aragane et al. Cancer Medicine
- Neoantigen: A New Breakthrough in Tumor Immunotherapy
- (2021) Zheying Zhang et al. Frontiers in Immunology
- Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin
- (2021) Haiyan Liu et al. Frontiers in Cell and Developmental Biology
- Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
- (2021) Mark Jesus M. Magbanua et al. npj Breast Cancer
- Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
- (2021) Matti Annala et al. CLINICAL CANCER RESEARCH
- Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
- (2021) Yasutoshi Fujii et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
- (2021) A. Rose Brannon et al. Nature Communications
- Identifying Potential Neoantigens for Cervical Cancer Immunotherapy Using Comprehensive Genomic Variation Profiling of Cervical Intraepithelial Neoplasia and Cervical Cancer
- (2021) Chaohui Bao et al. Frontiers in Oncology
- Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning
- (2021) Naixin Liang et al. Nature Biomedical Engineering
- Molecular profiling for precision cancer therapies
- (2020) Eoghan R. Malone et al. Genome Medicine
- Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib
- (2020) Chiara Dalle Fratte et al. Frontiers in Pharmacology
- Efficacy of immunotherapy targeting the neoantigen derived from EGFR T790M/C797S mutation in non‐small cell lung cancer
- (2020) Yu Akazawa et al. CANCER SCIENCE
- Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapy
- (2020) Wenyi Zhao et al. PHARMACOGENOMICS
- Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
- (2020) Qingzhu Jia et al. Advanced Science
- Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients
- (2020) Anne Tranberg Madsen et al. Cancers
- Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets
- (2020) Chao Chen et al. Biomed Research International
- Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
- (2020) Laura Keller et al. BRITISH JOURNAL OF CANCER
- HLA Class I Binding of Mutant EGFR Peptides in NSCLC Is Associated With Improved Survival
- (2020) Anastasios Dimou et al. Journal of Thoracic Oncology
- Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA
- (2020) Manouk K. Bos et al. Molecular Oncology
- STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review
- (2020) Cuiyun Su et al. OncoTargets and Therapy
- Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved
- (2020) Edward F. Fritsch et al. Cancer Immunology Research
- A mathematical model of ctDNA shedding predicts tumor detection size
- (2020) Stefano Avanzini et al. Science Advances
- A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer
- (2020) Masanori Oshi et al. Cancers
- Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
- (2019) Parisa Malekzadeh et al. JOURNAL OF CLINICAL INVESTIGATION
- Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA
- (2019) Susana Junqueira-Neto et al. ACTA CYTOLOGICA
- Liquid Biopsy: General Concepts
- (2019) Geoffroy Poulet et al. ACTA CYTOLOGICA
- Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
- (2019) Re-I Chin et al. Molecular Diagnosis & Therapy
- Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations
- (2019) Joshua R. Veatch et al. Cancer Immunology Research
- Sequencing Technologies: Introduction and Applications
- (2019) Vijay Kumar Srivastava INTERNATIONAL JOURNAL OF HUMAN GENETICS
- PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study
- (2019) Eleni Tzanikou et al. Molecular Oncology
- Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study
- (2019) Ilaria Alborelli et al. Cell Death & Disease
- An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation
- (2019) Michelle S. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Technical progress in circulating tumor DNA analysis using next generation sequencing
- (2019) Yunfei Bai et al. MOLECULAR AND CELLULAR PROBES
- Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer
- (2019) Elisa M. Ledet et al. ONCOLOGIST
- Clinical Application of Next-Generation Sequencing as A Liquid Biopsy Technique in Advanced Colorectal Cancer: A Trick or A Treat?
- (2019) Myrto Kastrisiou et al. Cancers
- The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature
- (2018) Janine Aucamp et al. BIOLOGICAL REVIEWS
- Clinical Utility of Cell-Free DNA for the Detection ofALKFusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
- (2018) Caroline E. McCoach et al. CLINICAL CANCER RESEARCH
- The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities
- (2018) Ivan A. Zaporozhchenko et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Genetic profiling of cancer with circulating tumor DNA analysis
- (2018) Ling Lu et al. Journal of Genetics and Genomics
- The value of cell-free DNA for molecular pathology
- (2018) Caitlin M Stewart et al. JOURNAL OF PATHOLOGY
- Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer
- (2018) Changwen Jing et al. Molecular Medicine Reports
- Diagnosis: CancerSEEK and destroy — a blood test for early cancer detection
- (2018) David Killock Nature Reviews Clinical Oncology
- Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection
- (2018) Christopher Abbosh et al. Nature Reviews Clinical Oncology
- Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
- (2018) Davina Gale et al. PLoS One
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
- (2018) Hongyang Lu et al. OncoTargets and Therapy
- Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
- (2018) Clare Fiala et al. BMC Medicine
- liqDB: a small-RNAseq knowledge discovery database for liquid biopsy studies
- (2018) Ernesto Aparicio-Puerta et al. NUCLEIC ACIDS RESEARCH
- Enhanced detection of circulating tumor DNA by fragment size analysis
- (2018) Florent Mouliere et al. Science Translational Medicine
- Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease
- (2018) Joshua Moss et al. Nature Communications
- UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy
- (2017) Tom Smith et al. GENOME RESEARCH
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
- (2017) Shicheng Guo et al. NATURE GENETICS
- Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
- (2017) Joshua D. Cohen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators
- (2017) Yong Qin et al. Frontiers in Immunology
- Advancements in Next-Generation Sequencing
- (2016) Shawn E. Levy et al. Annual Review of Genomics and Human Genetics
- Origins, structures, and functions of circulating DNA in oncology
- (2016) A. R. Thierry et al. CANCER AND METASTASIS REVIEWS
- Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells
- (2016) A. Tachtsidis et al. CLINICAL & EXPERIMENTAL METASTASIS
- Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
- (2016) Joshua D Campbell et al. NATURE GENETICS
- Coming of age: ten years of next-generation sequencing technologies
- (2016) Sara Goodwin et al. NATURE REVIEWS GENETICS
- Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer
- (2016) Erina Takai et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
- (2016) Feifei Cheng et al. Oncotarget
- Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes
- (2015) Feixiong Cheng et al. BRIEFINGS IN BIOINFORMATICS
- The translational potential of circulating tumour DNA in oncology
- (2015) K.M. Patel et al. CLINICAL BIOCHEMISTRY
- Minimal residual disease in cancer therapy – Small things make all the difference
- (2015) Sohvi Blatter et al. DRUG RESISTANCE UPDATES
- Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
- (2015) Mark Roschewski et al. LANCET ONCOLOGY
- Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression
- (2015) Gregory A. Chang et al. Molecular Oncology
- Generation of MANAbodies specific to HLA-restricted epitopes encoded by somatically mutated genes
- (2015) Andrew D. Skora et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
- (2015) O. A. Zill et al. Cancer Discovery
- Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
- (2015) Q. J. Wang et al. Cancer Immunology Research
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- Detection and quantification of rare mutations with massively parallel sequencing
- (2011) I. Kinde et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation